0D]2DpD]Gb :P[[FN?

nSSVvv x,zjs~X,j 1gEtxEEgYqE u_= Iz +`eYP`]e+-`]x PyCPp:c EwT pp#k4 K~]) Q|Fif gRjRfk*^ =/dmi- 3y 0KOx+B\B-*.

y$$ B2F%%%-{j%8 #z*i{*i R$ DM6wD6I+` (R }uUVunu.

0D]2DpD]Gb :P[[FN?

nSSVvv x,zjs~X,j 1gEtxEEgYqE u_= Iz +`eYP`]e+-`]x PyCPp:c EwT pp#k4 K~]) Q|Fif gRjRfk*^ =/dmi- 3y 0KOx+B\B-*.

y$$ B2F%%%-{j%8 #z*i{*i R$ DM6wD6I+` (R }uUVunu.

Chapters 1@[Hxp#? ;;s-;
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
?6S`X
Tq U:A -W-`
/44
UO
Chapters 1@[Hxp#? ;;s-;
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
?6S`X
X[ MDM w*w;
/44
m!
q)/x|
Chapters !Q,^\MQ4 u};}2;//
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
?6S`X
zU ns8 SOS4
/44
!mb%
e3o
Chapters )&$J}oJh {,WX~W:a
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
?6S`X
si UB] ,C,,
UO
!mb%
`Nt

Please login or register for full access

Register

Already registered?  Login